Evidence map›Paper›PMID 30609655›Full record

ArticleMarine drugs2019

Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative.

Jie-Fen Cui, Han Ye, Yu-Jie Zhu, Yin-Ping Li, Jing-Feng Wang, Peng Wang

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Regulatory Effects Mediated byFoods (Basel, Switzerland) · 2023
    Article
  7. Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Phosphatidylserine fromMarine drugs · 2020
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jie-Fen CuiCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. cjfouc@163.com.
Han YeCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. 17852720293@163.com.
Yu-Jie ZhuCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. zyjbmgf@163.com.
Yin-Ping LiCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. fmsboc@163.com.
Jing-Feng WangCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. jfwang@ouc.edu.cn.
Peng WangCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China. pengwang@ouc.edu.cn.
Ocean University of China · CNQingdao University of Science and Technology · CN

Funding

This work was supported by the National key research and development program 2018YFC0311203 and the Key Research and Development Program of Shandong 2018GHY115032. 2018YFC0311203 and 2018GHY115032
6 · The paper itself

Abstract

Polysaccharide chromium (III) derivatives are gaining increasing attention in improving type 2 diabetes. In this study, the sulfated polysaccharide from

Indexed as

AnimalsBlood GlucoseDeoxy SugarsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Disease Models, AnimalGlycogen Synthase Kinase 3 betaHyperglycemiaHypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsInsulin ResistanceMaleMannansMiceMice, Inbred C57BLBlood GlucoseDeoxy SugarsGlycogen Synthase Kinase 3 betaHypoglycemic AgentsInsulinInsulin Receptor Substrate ProteinsMannansPhosphatidylinositol 3-KinasePolysaccharidesProto-Oncogene Proteins c-aktrhamnanmolecular mechanismsafety evaluationstructure characterizationsulfated polysaccharide derivativetype 2 diabetes

Identifiers

PMID30609655
PMCPMC6356789
OpenAlexW2907715742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.